N-923
Norfluoxetine oxalate solution
1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
About This Item
Productos recomendados
grado
certified reference material
Nivel de calidad
Formulario
liquid
Características
Snap-N-Spike®/Snap-N-Shoot®
envase
ampule of 1 mL
fabricante / nombre comercial
Cerilliant®
concentración
1.0 mg/mL in methanol (as free base)
técnicas
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
aplicaciones
clinical testing
Formato
single component solution
temp. de almacenamiento
2-8°C
cadena SMILES
NCCC(C1=CC=CC=C1)OC2=CC=C(C(F)(F)F)C=C2.OC(C(O)=O)=O
InChI
1S/C16H16F3NO.C2H2O4/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12;3-1(4)2(5)6/h1-9,15H,10-11,20H2;(H,3,4)(H,5,6)
Clave InChI
FDWJCEPFCGIDPF-UHFFFAOYSA-N
Descripción general
Aplicación
- Forensic Detection of Cocaine and Antidepressants: Norfluoxetine is utilized in the development of an innovative analytical method using magnetic nanoparticles for the forensic detection of cocaine, antidepressants, and their metabolites in postmortem blood samples. This method represents a significant advance in forensic toxicology, providing rapid, sensitive, and reliable results essential for criminal investigations and legal proceedings (de Souza Schwarz et al., 2024).
- Ion Channel Research in Dermatology: Research involving Norfluoxetine investigates its effects on selected ion channels, highlighting its potential implications in skin physiology. This study explores the multifaceted roles of serotonin reuptake inhibitors like Norfluoxetine in dermatological applications, contributing to better understanding and treatment of skin-related disorders (Kim et al., 2023).
- Therapeutic Drug Monitoring: Norfluoxetine is featured in the simultaneous determination of serotonin selective reuptake inhibitors using an advanced UPLC MS-MS method. This method is used in clinical settings for therapeutic drug monitoring, ensuring proper dosage and optimizing treatment outcomes for patients undergoing antidepressant therapy (Eloisa Chávez-Castillo et al., 2022).
- Pharmacological Research on TREK and TRESK Channels: Studies involving Norfluoxetine examine its interaction with TREK and TRESK K2P channels, important for understanding the pharmacological properties of drugs affecting the central nervous system. Such research aids in the development of new therapeutic agents for neurological conditions (Walsh et al., 2021).
- Placental Aromatase Influence by SSRIs: Norfluoxetine is investigated for its impact on placental aromatase, a crucial enzyme in steroid hormone biosynthesis. Understanding how SSRIs affect this enzyme can improve safety profiles and therapeutic strategies during pregnancy, especially concerning fetal development (Hudon Thibeault et al., 2019).
Información legal
Producto relacionado
Palabra de señalización
Danger
Frases de peligro
Consejos de prudencia
Clasificaciones de peligro
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Órganos de actuación
Eyes,Central nervous system
Código de clase de almacenamiento
3 - Flammable liquids
Clase de riesgo para el agua (WGK)
WGK 1
Punto de inflamabilidad (°F)
49.5 °F - closed cup
Punto de inflamabilidad (°C)
9.7 °C - closed cup
Elija entre una de las versiones más recientes:
Certificados de análisis (COA)
Lo sentimos, en este momento no disponemos de COAs para este producto en línea.
Si necesita más asistencia, póngase en contacto con Atención al cliente
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico